Annual report pursuant to Section 13 and 15(d)

Notes Payable (Details Textual)

v3.7.0.1
Notes Payable (Details Textual) - USD ($)
1 Months Ended 10 Months Ended 12 Months Ended
Mar. 02, 2015
Oct. 25, 2016
Jul. 05, 2016
Jul. 29, 2015
Dec. 31, 2015
Dec. 31, 2016
Debt Instrument [Line Items]            
Percentage Of Warrants Issued On Outstanding Note Amount       25.00%    
Class of Warrants Or Rights Issued, Warrants Term       10 years    
Notes Payable, Related Parties, Current         $ 3,571,000 $ 320,000
Interest Expense, Debt         0 895,000
Amortization of Debt Discount (Premium)         0 $ 763,000
Working Capital Promissory Note [Member] | Fortress Biotech, Inc [Member]            
Debt Instrument [Line Items]            
Debt Instrument, Interest Rate, Stated Percentage           8.00%
Notes Payable, Related Parties, Current           $ 320,000
Interest Expense, Debt         $ 168,000 $ 253,000
National Securities Corporation Note [Member]            
Debt Instrument [Line Items]            
Debt Instrument, Interest Rate, Stated Percentage           8.00%
Interest Expense, Debt           $ 140,000
Percentage Of Contingently Issuable Warrants On Indebtedness Transferred     25.00%      
Debt Instrument, Face Amount   $ 3,600,000 $ 3,600,000      
Debt Related Commitment Fees and Debt Issuance Costs     $ 129,000      
Amortization of Debt Discount (Premium)           $ 763,000
Debt Instrument, Interest Rate, Effective Percentage     23.10%      
Debt Instrument, Unamortized Discount     $ 634,000      
Issuance Of Warrants, In Conjunction With Notes Payable   $ 138,462        
National Securities Corporation Note [Member] | Fortress Biotech, Inc [Member]            
Debt Instrument [Line Items]            
Proceeds from Issuance of Debt $ 10,000,000